Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 4/19/12 → 4/19/15 |
Funding
- PPD Development (WA25046 // WA25046)
- Genentech, Inc (WA25046 // WA25046)
Protocol # WA25046: A Phase III, Multicentre, Randomized, Parallel-Group, Double Blinded, Placebo Controlled Study to Evaluate the Efficacy and Safety of Ocrelizumab in Adults with Primary Progressive Multiple Sclerosis"
- Cohen, Bruce A (PD/PI)
Project: Research project